Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer
The recent inclusion of targeted biologic agents in guideline recommendations has provided oncologists with more treatment options and patients with the potential for improved outcomes. However, these additional options also increase the complexity of treatment selections and appropriate sequencing of treatments for patients with gastric and gastroesophageal (GEJ) cancers.
Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer will guide community clinicians in making consistent, evidence-based management choices with treatments that are appropriately sequenced. Guidance will also be provided for the management of possible treatment side effects and the integration of emerging therapies into treatment regimens as new clinical-trial data mature.
- Evaluate the current evidence across multiple lines of therapy and appropriately sequence therapies for gastric and GEJ cancers
- Mitigate toxicities associated with gastric cancer treatment regimens to improve patient outcomes
- Evaluate the safety and efficacy data for emerging therapies for gastric and GEJ cancers
This activity is intended for community-based medical oncologists, surgical oncologists, radiation oncologists, oncology nurses, and the rest of the multidisciplinary cancer care team for gastric and GEJ cancers.
AMA PRA Category 1 Credit™: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe Oncology. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
For information about the CME/MOC accreditation of this program, please email: email@example.com.
Nursing Credit: Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
For information about the CNE accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
Mariela Blum Murphy, MD
MD Anderson Cancer Center
University of Texas
K. Robert Shen, MD
Associate Professor of Surgery
Department of Surgery
Division of General Thoracic Surgery
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control content of a continuing medical education program provided by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards of Commercial Support in advance of delivery of the activity to learners.
Disclosures will be made known to the participants prior to the activity.
The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.
Event staff will be glad to assist you with any specials needs (e.g. physical, dietary, etc.). Please email email@example.com at least 5 days prior to the program.
Jointly provided by the Potomac Center for Medical Education and Rockpointe Oncology
Jointly provided by Global Education Group and Rockpointe Oncology
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Utah Program Faculty
Mariela Blum Murphy, MD
Assistant ProfessorMD Anderson Cancer CenterUniversity of TexasHouston, TX
Chicago Program Faculty
Al B. Benson III, MD, FACP, FASCO
Professor of Medicine, Division of Hematology/Oncology
Northwestern University’s Feinberg School of Medicine
Associate Director of Cooperative Groups
Robert H. Lurie Comprehensive Cancer Center